Status:
COMPLETED
Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia
Lead Sponsor:
Cairo University
Conditions:
Hypertensive Disorder of Pregnancy
Eligibility:
FEMALE
18-40 years
Brief Summary
Laboratory monitoring of patients included serial measurement of complete blood cell count, liver function tests, coagulation profile, and renal function tests. ICU management during conduction of th...
Detailed Description
Laboratory monitoring of patients included serial measurement of complete blood cell count, liver function tests, coagulation profile, and renal function tests. ICU management included the following:...
Eligibility Criteria
Inclusion
- women with severe preeclampsia or eclampsia or HELLP syndrome admitted to ICU
Exclusion
- Non eclamptic causes of fits, including hysterical causes and epilepsy
- \-
Key Trial Info
Start Date :
October 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2017
Estimated Enrollment :
1238 Patients enrolled
Trial Details
Trial ID
NCT03412552
Start Date
October 1 2015
End Date
December 30 2017
Last Update
January 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy medical school
Cairo, Egypt, 12151